| __timestamp | Amphastar Pharmaceuticals, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 55962693 |
| Thursday, January 1, 2015 | 37065000 | 78655788 |
| Friday, January 1, 2016 | 41199000 | 95723069 |
| Sunday, January 1, 2017 | 43415000 | 116808575 |
| Monday, January 1, 2018 | 57564000 | 106397017 |
| Tuesday, January 1, 2019 | 68853000 | 108431600 |
| Wednesday, January 1, 2020 | 67229000 | 141426832 |
| Friday, January 1, 2021 | 60932000 | 225200000 |
| Saturday, January 1, 2022 | 74771000 | 297812160 |
| Sunday, January 1, 2023 | 73741000 | 283614139 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, MorphoSys AG and Amphastar Pharmaceuticals, Inc. have demonstrated their commitment to research and development (R&D) with significant investments. From 2014 to 2023, MorphoSys AG consistently outpaced Amphastar, investing nearly 150% more in R&D on average. In 2022, MorphoSys AG's R&D expenses peaked at approximately 298 million, a staggering 300% increase from 2014. Meanwhile, Amphastar's R&D spending grew steadily, reaching around 75 million in 2022, marking a 160% rise over the same period. This trend highlights MorphoSys AG's aggressive strategy to lead in innovation, while Amphastar maintains a steady growth trajectory. As the pharmaceutical landscape evolves, these investments could be pivotal in shaping the future of healthcare.
Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Teva Pharmaceutical Industries Limited vs MorphoSys AG
Analyzing R&D Budgets: United Therapeutics Corporation vs MorphoSys AG
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and MorphoSys AG
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs MorphoSys AG
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and MorphoSys AG
PTC Therapeutics, Inc. vs MorphoSys AG: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for MorphoSys AG and Wave Life Sciences Ltd.
Research and Development: Comparing Key Metrics for MorphoSys AG and Celldex Therapeutics, Inc.
MorphoSys AG or MiMedx Group, Inc.: Who Invests More in Innovation?
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending